Products and Resources Catalog

Thomas McMahon, PhD, Yale University School of Medicine, delivered a didactic presentation on how PPW programs can better serve fathers and partners. The presentation discussed the importance of engaging men, facts about fathers and fathering, and considerations for building programming for fathers.

Karol Kaltenbach, PhD, Emeritus Professor of Pediatrics at Sidney Kimmel Medical College, delivered a didactic presentation on trauma-informed and trauma-specific services in the context of a PPW program. The presentation discussed how this approach and services fit into the context of family-centered treatment and reviewed available resources and training curricula for staff.

Kathryn Icenhower, PhD, CEO of SHIELDS for Families in Compton, CA delivered a didactic presentation on services for younger children (birth to age 5). The presentation covered what comprises a quality early childhood education program, developmental domains, program design, developmental assessment, services strategies, and staffing.

Opioid Use Disorders are a growing concern across the US, particularly its impact on pregnant women and children. In this webinette, Dr. Jones will present information to put this issue and the treatment of women during pregnancy into context, medications available to treat OUDs in pregnant women, including a review of study outcomes, as well as presentation of questions still to be answered.

ATTC Center of Excellence Director, Pat Stilen, and Steering Committee Chair, Lonnetta Albright, delivered a didactic presentation on family-centered care during the first session of PPW Project ECHO. Their presentation summarized the ATTC Center of Excellence’s integrated framework of family-centered recovery and wellness that incorporates perspectives from the PPW, substance use disorder/recovery, and health care fields.

In this paper, the ATTC pre-service education workgroup addresses how such advancements must progress so that health professionals will be equipped to appropriately care for patients who have, or who are at risk of developing, SUD seven generations into the future.

Co-occurring disorders (CODs) occur frequently and can significantly impact mother and child. In this webinette, Dr. Cooke will present information on the significance of CODs and their risk factors; discuss the importance of repeat screening, appropriate referral, and coordinated treatment; and share the safety profiles of the various medications available to treatment CODs and how to take in account the risks to mother and child.

3-hour, self-paced course designed to enhance professional knowledge of MAT and build skills related to educating clients about MAT.

Where you live impacts where you access services, develop supportive relationships, work or go to school. Housing is one of the pillars of recovery. And yet, accessing safe, affordable housing in neighborhoods of choice can be challenging for women and families who are experiencing both substance use disorders and poverty.

For women of color and/or women with tribal affiliation, healing approaches from the chronic diseases of addiction and mental health problems are most successful when they include information on historical trauma as well as on cultural practices that contribute to a sense of comfort, well-being, and spirituality.

Substance abuse is a primary reason why many families end up in the child welfare system. In this webinar, we will discuss the program design and funding strategies that can enable providers to keep families together by providing Family Centered Treatment.

Pregnant women with Opioid Use Disorder present with a host of special maternal care needs. Studies have found that both Methadone and Buprenorphine have helped to reduce illicit drug use behaviors and promote pre-natal care. Research also suggests that medication assisted treatment with opioid agonists may influence positive birth outcomes, however, this medical intervention must be delivered wi

The effects of prenatal alcohol exposure represent a leading preventable cause of developmental delays in the United States. Fetal alcohol spectrum disorders (FASD) represent the range of lifelong effects that can occur, including cognitive, behavioral, and/or social deficits. This lunch break will provide an overview of FASD and provide resources to adapt women’s treatment programs to increase success for women with an FASD.

Dr. Thomas E. Freese, Director of the Pacific Southwest ATTC, explains what is meant by "medical" marijuana, who uses it and why, and the difference between medical marijuana and FDA approved medications.

Q&A with marijuana expert Dr. Kevin Hill. Topics include Addiction/dependency, adolescence, effects on the body, medical marijuana, potency, and withdrawal.

Dr. Laura Borgelt, Professor at the University of Colorado Skaggs School of Pharmacy, discusses the effects marijuana use can have on women who are pregnant, breastfeeding, the unborn child, and newborns.

This presentation demonstrated how to use Motivational Interviewing with adolescents. Presented by Nadine Mastroleo, Ph.D. This presentation is proprietary.

Expert presenter bios at the 2015 Improving Care for Substance Use, HIV and/or HCV in Adolescents: Effective Approaches for Assessing, Treating, and Engaging Teens

Adolescent Conference 2015 - Agenda

Dr. Kari Franson from the University of Colorado's Skaggs School of Pharmacy and Pharmaceutical Sciences shares information on the long-term negative outcomes marijuana use has on developing adolescents.

Under Federal law, marijuana is still an illegal substance, yet 23 states and Washington DC have legalized medical marijuana, and four states have decriminalized marijuana for recreational use. With this shift in policy and many other states expected to follow suit, we will need to consider ways to address the growing impact and consequences of legalization. Dr. Rosalie Pacula, Director of the Bing Center for Health Economics at the RAND Corporation, will examine in this video the variance

ATTC Network Efforts and Activities in Integrating Substance Use Disorder and Health Care Services

Dr. Wilson M. Compton, Deputy Director at NIDA, highlights the adverse effects of marijuana use can have on the brain, heart, and respiratory. The video also provides some information on second hand exposure and current marijuana potency.

Eight, 1-page color infographics (Four in English, four in Spanish) covering 1) Effects on the body 2) Use and educational outcomes, 3) Effects on pregnancy and newborns, and 4) Medical use.